Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Sales | 231,277 | 216,652 | 207,074 | 249,346 | 236,602 |
| Cost of Goods | 21,382 | 23,491 | 24,340 | 23,283 | 25,605 |
| Gross Profit | 209,895 | 193,161 | 182,734 | 226,063 | 210,997 |
| Operating Expenses | 150,347 | 136,552 | 146,126 | 142,164 | 144,570 |
| Operating Income | 59,930 | 57,100 | 36,948 | 84,182 | 67,032 |
| Interest Expense | 112 | 71 | 77 | 402 | 25 |
| Other Income | 883 | 1,839 | 976 | 1,092 | 2,052 |
| Pre-tax Income | 60,701 | 58,868 | 37,847 | 84,872 | 69,059 |
| Income Tax | 15,455 | 12,784 | 7,345 | 22,633 | 17,582 |
| Net Income Continuous | 45,246 | 46,084 | 30,502 | 62,239 | 51,477 |
| Minority Interests | 731 | 289 | 286 | 328 | 128 |
| Net Income | $44,515 | $45,795 | $30,216 | $61,911 | $51,349 |
| EPS Basic Total Ops | 0.44 | 0.45 | 0.30 | 0.61 | 0.50 |
| EPS Basic Continuous Ops | 0.44 | 0.45 | 0.30 | 0.61 | 0.50 |
| EPS Diluted Total Ops | 0.43 | 0.45 | 0.29 | 0.60 | 0.50 |
| EPS Diluted Continuous Ops | 0.44 | 0.45 | 0.30 | 0.61 | 0.50 |
| EBITDA(a) | $74,605 | $72,863 | $52,291 | $99,632 | $83,955 |